Skip to content

FDA INSPECTIONS

Pass Your FDA Inspections!

Menu
  • accounts
    • create account
    • login
    • my account
    • user profile
  • contact
×
Breaking News:
  • FDA CDRH Issues Letters to Manufacturers of Adulterated and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
  • The United States and European Union will be able to use each other’s Pharmaceutical Inspections
  • US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue
  • US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.
  • Hospira Warning Letter Issued by US FDA

Medical Devices

Medical Devices 
August 15, 2020August 15, 2020

FDA CDRH Issues Letters to Manufacturers of Adulterated and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

Posted By: fdainspections

On August 12, 2020, The U.S. Food and Drug Administration’s Center of Devices and Radiological Health FDA CDRH issued 4 letters to Labs and

Read more

Recent Posts

  • FDA CDRH Issues Letters to Manufacturers of Adulterated and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)
  • The United States and European Union will be able to use each other’s Pharmaceutical Inspections
  • US FDA Issues Warning Letter to DeGrave Dairy for Illegal Drug Residue
  • US FDA Issues Warning Letter to Lucky Pacific Corp and Kamli International Co. Ltd.
  • Hospira Warning Letter Issued by US FDA
Terms and Conditions
Privacy

Newsletter

Copyright © 2021 FDA INSPECTIONS. Theme: ColorNews by ThemeGrill. Powered by WordPress.